Aegerion Pharmaceuticals, Inc…. (NASDAQ:AEGR) Stock Price & News

6 Biopharma Movers Making a Run on Wednesday

The broad markets appeared to be turning around in Wednesday’s session after posting losses in the past four sessions. One reason for this resurgence is a few biopharma companies making ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Water, Autodesk, Kraft Heinz, Palo Alto, Toyota, Vipshop and More

Stocks were indicated to open higher on Friday morning, and it appears as though there will be another positive week for stocks. Maybe investors are migrating from selling every rally back ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aegerion, Amazon, EMC, McDonald’s, MetLife, Microsoft, SanDisk, Tyco and More

Stocks were indicated higher on Wednesday after Tuesday's minor recovery that broke the losing streak for stocks. Some excitement is around Mario Draghi and ECB quantitative easing expectations, but the ...
Read Full Story »

6 Serious Earnings Disappointments That Smacked Shareholders

Tuesday's trading session mixed after having been lower, so the markets are trying to snap the recent losing streak. Many companies are still reporting third quarter earnings, and some of ...
Read Full Story »
153576724

Aegerion Pharmaceuticals Plunges to New 52-Week Low

Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) reported its third-quarter results Thursday after the market close as -$0.12 in earnings per share and $43.7 million in revenue, against Thomson Reuters consensus estimates ...
Read Full Story »
Wall Street/NYSE

Why Are 5 Stocks Way Down on an Up Day?

The big boost to equities following Friday morning’s announcement of additional quantitative easing by the Bank of Japan has been spread widely across most sectors. Still there are several laggards ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Aegerion, Avon, Atmel, LinkedIn, Ocwen, Visa and More

Stocks screamed higher on Friday on a surprise Japan expansion of its own stimulus and quantitative easing measures. Investors have proved, even during October, that they are willing to buy ...
Read Full Story »
biotech

Companies Betting on the Next 10 Blockbuster Drugs

The biotech sector has seen its valuations hit hard in many cases in 2014, but many investors remain excited about the future wave of big biotech drugs -- and big ...
Read Full Story »
Wall St Bull statue

Merrill Lynch Changes to Small and Mid-Cap Alpha List

Bank of America Merrill Lynch is making changes to its Small and Mid Cap Alpha List, a list of companies that have $1 billion to $5 billion market caps at ...
Read Full Story »
95992888

Can Aegerion Still Rise 70%?

Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) should have a slogan that says "We love volatility." The biotech stock now trades for just under $60 after its earnings report, but the 52-week ...
Read Full Story »
BestBuy storefront OK

Jefferies Quality Stocks to Buy That Are Down but Not Out

Once the panic starts to set in a little, the stocks that are the first candidates for a trip to the woodshed are the momentum names. Momentum investors typically buy ...
Read Full Story »
JPMorgan_logo

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Biotechnology was an incredible performer in 2013, outperforming the S&P 500 by a stunning 36%. The analysts at J.P. Morgan think that the huge outperformance may lessen but can stay ...
Read Full Story »
131772836

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

With the Federal Reserve reminding investors yesterday that it can raise or lower asset purchases in its quantitative easing program based on the data, all eyes shift to tomorrow's employment ...
Read Full Story »
biotech

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

Biotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that expectations are very high and many of the stocks have ...
Read Full Story »

Secondary Offerings To Watch For Impact (AEGR, DPM, SIX, WAVX, FVE)

Secondary offerings matter.  They can raise capital for a company and they can help previous investors book profits.  They can also cause severe pressure on shares.  We have seen either ...
Read Full Story »